Replies to post #434481 on Amarin Corp Plc (AMRN)

[JRoon71]

RMB, got it. I assumed you were referring to Denner's work with Amarin.

As far as Amarin's circumstances, I actually DO believe that Amarin would be in the same, or better position with prior management.

Sarissa has INTENTIONALLY withheld support of the stock price, AND gone dark from a marketing/PR perspective. They have literally gone silent for 18+ months while the stock price has crumbled. And most of what has occurred operationally was already in motion when they took over (country approvals, rollouts, etc.).

The only positive I can point to with Sarissa is the swiftness and depth of their cost cutting. But at the same time, I do feel that some of the cuts and personnel decisions are foolhardy. The CEO position is a perfect example. I don't believe Aaron Berg has the depth of experience or skill to be CEO of this company. Obviously, they believe that he is simply CEO in name only; a figurehead. Sarissa is doing to real decision-making.

The comment about seeing into the future was concerning the Bioverativ litigatiion.
If you don't think Amarin would be in this same position or worse with prior management I don't know what to tell you.